Impact of denosumab use on the survival of untreated non-squamous non-small cell lung cancer patients with bone metastases
ConclusionsOur results suggest that treatment with denosumab may improve the overall survival of non-squamous NSCLC patients with BM.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer | Reclast | Xgeva | Zometa